Molecular Cytogenetics is Estimated to Witness High Growth Owing to Rising Prevalence of Genetic Disorders

 

Molecular Cytogenetics Market

Molecular cytogenetics is a branch of cytogenetics that utilizes molecular biology techniques such as fluorescence in situ hybridization (FISH) and polymerase chain reaction (PCR) to identify and locate genes and chromosomal features to diagnose genetic abnormalities at a molecular level. It is widely used for the detection of genetic diseases and cancers. It helps in timely detection and prognosis of genetic diseases and tailoring personalized treatment plans.

The global molecular cytogenetics market is estimated to be valued at US$ 4,211.4 Mn in 2023 and is expected to exhibit a CAGR of 24.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:
The rising prevalence of genetic disorders attributed to changing lifestyle patterns is a key driver boosting the growth of the global molecular cytogenetics market over the forecast period. As per CDC estimates, over 4,000 rare disorders affect over 350 million people worldwide. Additionally, increasing investments in genomics and precision medicine is also fueling the adoptions of molecular cytogenetics tests for early and accurate diagnosis. Furthermore, increasing R&D activities in the field of cancer genomics to develop novel cytogenetic tests and biomarkers will bolster the growth of the market.

SWOT Analysis

Strength: Molecular cytogenetics offers high-resolution methods to detect genetic abnormalities at the chromosome level. It helps in better diagnosis of genetic disorders, cancer profiling and prenatal testing. Techniques like FISH and SKY provide visualization of chromosome abnormalities with high sensitivity and specificity. Furthermore, advancements in molecular cytogenetics techniques and platforms are improving disease diagnosis and prognosis determination.
Weakness: Molecular cytogenetics techniques require specialized equipment, expertise and longer turnaround times for complex testing. High costs involved in setting up core laboratories for Molecular cytogenetics limits its adoption. Interpretation of complex chromosomal rearrangements through molecular tools still remains challenging.
Opportunity: Growing incidence of genetic disorders, cancer and rising focus on precision medicine is driving the demand for advanced diagnostics. Expanding applications of molecular cytogenetics in research and clinical practice presents significant growth opportunities. Developing countries provide scope to enhance penetration of molecular cytogenetics services.
Threats: Precision diagnostic methods like NGS based genome/exome sequencing are emerging as alternatives to molecular cytogenetics techniques. Competition from emerging low-cost POC testing devices poses threats. Stringent regulatory approvals and reimbursement challenges also impact market growth.

Key Takeaways

The global Molecular Cytogenetics Market Demand is expected to witness high growth driven by growing incidence of genetic disorders, cancer and expansion of applications in research and clinical settings. Molecular cytogenetics provides high resolution detection of genetic abnormalities compared to conventional cytogenetics techniques, aiding in better diagnoses.

Regional analysis: North America currently dominates the market owing to advancements in molecular technology platforms, availability of skilled workforce and favorable reimbursement policies. Asia Pacific is expected to emerge as the fastest growing regional market during the forecast period supported by expanding health infrastructures, large patient pools and focus on precision medicines particularly in China, India and Japan.

Key players: Key players operating in the Molecular Cytogenetics market are Abbott Laboratories, Affymetrix, Inc., Agilent Technologies, Inc., Applied Spectral Imaging, Inc., BI Biological Industries, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., CytoTest Inc., Cytognomix, Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Bionano Genomics, Inc., Precipio, Inc., and Leica Biosystems. These players are focusing on new product launches, collaborations and geographic expansions to strengthen their market position.

Get more insights on this topic: https://www.ukwebwire.com/molecular-cytogenetics-market-demand-share-analysis/

Comments

Post a Comment

Popular posts from this blog

The Notchback Market is Estimated To Witness High Growth Owing To Rising Demand From Emerging Economies

Image
  Notchback Market Market Overview: A notchback is a body style of cars characterized by a gently sloped rear window and greenhouse. Notchbacks provide practical interior space with good cargo capacity. They offer balanced interior volume for passengers and cargo along with sleek and stylish exterior design. The body style has advantages like no C-pillar which enhances visibility compared to sedans. Market key trends: The growth of the notchback market is attributed to rising demand from emerging economies like China, India and Brazil. These nations have growing middle-class population and increasing disposable income which is driving vehicle ownership. Moreover, notchback body style is quite popular in these developing markets due to its spacious cabin combined with stylish looks at affordable prices. Leading automakers are launching various notchback models to cater to the surging demand from developing countries, which is fueling the growth of the notchback market size during ...
Read more

The Bladder Liners Market Is Estimated To Witness High Growth Owing To Rising Prevalence Of Urinary Incontinence

Image
  Bladder Liners Market Market Overview: Benzodiazepines are a class of psychoactive drugs belonging to the benzodiazepine family. These drugs are prescribed for various medical conditions such as anxiety disorders, panic disorders, insomnia, seizures, alcohol withdrawal syndrome, muscle spasms, and as an anesthesia aid. Some common examples of benzodiazepines include alprazolam, clonazepam, diazepam, and lorazepam. These drugs work by increasing the action of gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the central nervous system. Due to their calming properties, they are widely used to treat insomnia, anxiety, panic attacks, agitation, seizures, muscle spasms, and alcohol withdrawal. Market Dynamics: The Benzodiazepine Drugs Market is primarily driven by the rising prevalence of anxiety disorders worldwide. As per Anxiety and Depression Association of America, anxiety disorders are the most common mental illness in the U.S., affecting nearly 40 million ...
Read more

Commercial Drones Market is Poised to Register Notable Growth Owing to Expanding Usage Across Varied Industries

Image
  Commercial Drones Market  The commercial drones market has been gaining significant traction over the recent years primarily driven by expanding deployment across various industries including agriculture, infrastructure, disaster management, and transportation among others. Commercial drones offer several advantages including cost-effectiveness, flexibility, precision and real-time monitoring capabilities. Meanwhile, growing popularity of drone delivery services across e-commerce as well as healthcare sectors has further catalyzed the market growth. Drones help in reducing operational costs while effectively meeting the target delivery timelines. Additionally, continuous technological advancements have resulted in miniaturization and development of drones with increased payload capacity and battery life. The Global commercial drones market is estimated to be valued at US$ 22.29 Bn in 2024 and is expected to exhibit a CAGR of 13% over the forecast period 2024 to 2031. Key T...
Read more